QIAGEN N.V. (QGEN) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 22, 2025
QIAGEN N.V. (QGEN) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
QIAGEN N.V. (Stock Symbol: QGEN)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
a major market leader with significant institutional backing.
Financial Performance & Key Metrics Analysis
Market Capitalization: $11177 million - Classified as a
large-cap stock with institutional-grade stability.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for QIAGEN N.V. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
QIAGEN N.V. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence
.
.
QIAGEN N.V. Stock Price Chart and Technical Analysis
Loading chart data...
Loading QIAGEN N.V. interactive price chart and technical analysis...
Deep dive into QIAGEN N.V.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if QIAGEN N.V. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For QIAGEN N.V.:
P/B Ratio3.13x
Market Cap$11177M
Book Value/Share$15.88
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently QIAGEN N.V. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For QIAGEN N.V.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess QIAGEN N.V.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For QIAGEN N.V.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal QIAGEN N.V.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For QIAGEN N.V.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively QIAGEN N.V. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For QIAGEN N.V.:
Understanding Financial Statement Data
What these metrics mean: Key figures from QIAGEN N.V.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For QIAGEN N.V.:
Income Statement ($ Millions)
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding225M
QIAGEN N.V. (QGEN) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for QIAGEN N.V. stock analysis.
Loading fundamental data...
Loading QIAGEN N.V. comprehensive fundamental analysis and insider trading data...
Latest QIAGEN N.V. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting QIAGEN N.V. (QGEN) stock price and investment outlook.
Qiagen N.V. has released its quarterly report for the period ended June 30, 2025, prepared under U.S. GAAP. The report highlights financial performance, including an increase in total assets to $5.82 ...
Qiagen NV (NYSE:QGEN) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 revenue is $523.70 million, and the earnings are expected to come in at $0.52 per ...
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing ...
March 12, 2025 — 06:54 am EDT Written by Zacks Equity Research for Zacks -> QIAGEN N.V. ’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics.
Qiagen NV (NYSE:QGEN) is set to release its Q1 2025 earnings on May 8, 2025. The consensus estimate for Q1 2025 revenue is $467.29 million, and the earnings are expected to come in at $0.43 per ...
Qiagen NV (QGEN) is evaluating selling a minority stake in its bioinformatics division, which may value the business at more than $1 billion.The diagnostics firms is working with an ...
Qiagen N.V. has announced a notification from the Netherlands Authority for the Financial Markets (AFM) regarding its institution, disclosing significant voting rights held by BlackRock, Inc.
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2025. Press release date / time: Wednesday, May 7, shortly after 22:05 Frankfurt ...
In 2014, Qiagen reported that its sales grew by just 4% to $1.35 billion (at constant currency exchange rates); however, remove the headwind from a 40% drop in U.S. HPV testing sales and revenue ...
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing ...
QIAGEN N.V. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of QIAGEN N.V. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Our AI model demonstrates 21% historical accuracy for QGEN predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence QIAGEN N.V. stock price forecasts?
Based on our AI analysis, QIAGEN N.V. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are QIAGEN N.V. forecasts updated?
QIAGEN N.V. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced QIAGEN N.V. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for QIAGEN N.V. stock.
